Vimarsana
Biggest News Aggregation in the World

Page 35 - Heca News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Heca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Heca Today - Breaking & Trending Today

Tri-City grad's anxiety kits for kids win international praise and help thousands - Vimarsana News

Tri-City grad's anxiety kits for kids win international praise and help thousands

“I really want to be able to be that example, especially for young kids, to show that it’s OK to talk about your struggles...”

Source: aol.com
Most Gulf markets end lower, Egypt ekes out gains - Vimarsana News

Most Gulf markets end lower, Egypt ekes out gains

Most stock markets in the Gulf ended lower on Sunday as investors focus in on the prospects of more Federal Reserve interest rate hikes as the U.S. closes in on a deal to raise its debt ceiling.

Investors in UAE hospital chain Aster eye $300 million India stake sale - Vimarsana News

Investors in UAE hospital chain Aster eye $300 million India stake sale

Investors in Aster DM Healthcare are in talks to sell a 30% stake in the company's India business for about $300 million, two sources with direct knowledge said, the latest potential deal in India's booming healthcare sector.

Exclusive: EU, Pfizer/BioNTech to amend COVID vaccine contract - Vimarsana News

Exclusive: EU, Pfizer/BioNTech to amend COVID vaccine contract

The European Union and drugmakers Pfizer and BioNTech said on Friday they had reached a deal to amend a COVID-19 vaccine contract, cutting the number the EU must buy and pushing the delivery deadline to 2026.

EU regulator recommends revoking authorisation for Novartis' sickle cell drug - Vimarsana News

EU regulator recommends revoking authorisation for Novartis' sickle cell drug

The European Medicines Agency (EMA) said on Friday it had recommended revoking marketing authorisation for Novartis' sickle cell disease drug Adakveo.